Compare Fox Corp Class B (FOX) vs Medtronic PLC (MDT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fox Corp Class B vs Medtronic PLC — how do they compare? Fox Corp Class B trades at $55.42 (market cap $25.36B), while Medtronic PLC trades at $88.24 (market cap $112.24B). The key difference: Medtronic PLC is far larger — about 4.4× Fox Corp Class B's market cap, and Medtronic PLC pays the higher dividend (3.28%). Which is the better fit depends on your goals — on Pluang, investors hold Fox Corp Class B for 75 Days and Medtronic PLC for 63 Days on average.
| FOX | MDT | |
|---|---|---|
Market Cap | $25.36B | $112.24B |
Volume | 886,620 | 105,663,236 |
Sector | Media | Health |
52-Week High | $67.76 | $105.35 |
52-Week Low | $44.39 | $73.75 |
Typical Hold Time | 75 Days | 63 Days |
Enterprise Value | $28.72B | $131.58B |
Dividend Yield | 1.02% | 3.28% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FOX trades at $56.13, up 0.27% today, with a bullish technical signal from moving averages and a consensus analyst price target of $84.75 implying significant upside. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $1.79 surpassing the $1.44 estimate. Fundamentals show robust growth, with 2025 revenue reaching $16.30 billion and net income margin improving to 13.88%.
The outlook is positive given valuation multiples below industry averages and consistent earnings outperformance, but risks include a projected net cash flow decline in 2026 and competitive pressures in the media sector. Investor sentiment is mixed, with analyst ratings nearly evenly split between Buy and Hold.
Medtronic (MDT) trades at $87.80, up 2.68% today, with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with a 13.93% net income margin and consistent dividend growth over 49 years. Revenue growth accelerated to $33.54B in 2025, and analyst consensus targets $97.80, implying 11% upside. Recent news highlights regulatory approvals for medical devices and a $4B MiniMed exchange offer.
MDT offers value with a 3.2% dividend yield and reasonable valuation (P/E 21.6), but faces headwinds from technical bearishness and rising debt. The stock's appeal hinges on execution of growth initiatives in cardiovascular and neuroscience segments, though competitive and macroeconomic risks persist.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Fox Corp Class B
Fox represents the assets not sold to Disney by the predecessor firm, Twenty First Century Fox. The remaining assets include Fox News, the FOX broadcast network, FS1 and FS2, Fox Business, Big Ten Network, 28 owned and operated local television stations of which 17 are affiliated with the Fox Network, and the Fox Studios lot. The Murdoch family continues to control the successor firm, which represents a large-scale bet on the value of live sports and news in the U.S. market.
Read more on FOX →About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →
